"RYTARY Drug Profile, 2024This report focuses on RYTARY and covers the following critical aspects of this drug:United States patentsExpired United States patentsFDA Paragraph IV patent challengesDistrict Court patent litigationClinical trialsDrug pricesAnnual sales revenuesFinished product suppliersRaw active pharmaceutical ingredient (API) sourcesFREE UPDATE: Send your receipt to DrugPatentWatch within 30 days for a free update
"